APROTININ Side Effects

6812284-0 | Device Alarm Issue
on May 12, 2010 Female patient from CANADA , 73 years of age, weighting 207.2 lb, was diagnosed with aortic valve replacement, anaesthesia and was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: device alarm issue. Aprotinin dosage: Test Dose. During the same period patient was treated with SUFENTANIL (View Sufentanil Review and Sufentanil Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ROCURONIUM (View Rocuronium Review and Rocuronium Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), UNFRACTIONED HEPARIN (View Unfractioned Heparin Review and Unfractioned Heparin Label ), PROPOFOL (View Propofol Review and Propofol Label ).

6738767-X | Device Alarm Issue
Patient was taking Aprotinin (View Usage). Patient had the following side effects: device alarm issue on May 12, 2010 from CANADA Additional patient health information: Female patient , 73 years of age, weighting 207.2 lb, was diagnosed with aortic valve replacement, anaesthesia and. Aprotinin dosage: Test Dose. During the same period patient was treated with SUFENTANIL (View Sufentanil Review and Sufentanil Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), ISOFLURANE (View Isoflurane Review and Isoflurane Label ), UNFRACTIONED HEPARIN (View Unfractioned Heparin Review and Unfractioned Heparin Label ), PROPOFOL (View Propofol Review and Propofol Label ).

5840044-6 | Renal Artery Thrombosis, Renal Failure Acute
Adverse event was reported on Oct 31, 2007 by a Female patient taking Aprotinin (View Usage) (Dosage: ) was diagnosed with surgery (What is surgery?) and. Location: UNITED STATES , 42 years of age, After Aprotinin was administered, patient had the following side effects: renal artery thrombosis, renal failure acute.

5840040-9 | Anaphylactic Shock, Hypotension, Obstructive Airways Disorder
on Aug 08, 2007 Male patient from UNITED STATES , 66 years of age, was diagnosed with mitral valve repair, cardiac failure congestive, atrial fibrillation (What is atrial fibrillation?), anaesthesia and was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, hypotension, obstructive airways disorder. Aprotinin dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ). Patient was hospitalized.


5840032-X | Renal Failure Acute
on Oct 31, 2007 Female patient from UNITED STATES , 81 years of age, was treated with Aprotinin (View Usage). Patient had the following side effects: renal failure acute. Aprotinin dosage: .

5819050-3 | Aortic Thrombosis, Cardiac Arrest, Intracardiac Thrombus, Procedural Complication, Right Ventricular Failure
Patient was taking Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: aortic thrombosis, cardiac arrest (What is cardiac arrest?), intracardiac thrombus, procedural complication, right ventricular failure on Jul 18, 2008 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with coagulation time abnormal, bacteraemia and. Aprotinin dosage: . During the same period patient was treated with NOVOSEVEN (View Novoseven Review and Novoseven Label ), PROTAMINE SULFATE (View Protamine Sulfate Review and Protamine Sulfate Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

5773398-X | Anaphylactic Reaction, Bradycardia, Bronchospasm, Cardiac Arrest, Shock
Adverse event was reported on Jun 06, 2008 by a Female patient taking Aprotinin (View Usage) (Dosage: ) was diagnosed with underdose, induction of anaesthesia, maintenance of anaesthesia and. Location: PORTUGAL , 56 years of age, weighting 191.8 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, bradycardia, bronchospasm, cardiac arrest (What is cardiac arrest?), shock. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MORPHINE (View Morphine Review and Morphine Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), DEXTROSE (View Dextrose Review and Dextrose Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ).

5743743-X | Bradycardia, Cardiac Disorder, Cardiac Failure Congestive, Disseminated Intravascular Coagulation, Hypotension, Supraventricular Tachycardia, Ventricular Fibrillation
on Mar 19, 2008 Male patient from UNITED STATES , 65 years of age, was diagnosed with elective surgery and was treated with Aprotinin (View Usage). Patient had the following side effects: bradycardia, cardiac disorder, cardiac failure congestive, disseminated intravascular coagulation, hypotension, supraventricular tachycardia, ventricular fibrillation. Aprotinin dosage: As Used: 1 Ml.

5734999-8 | Anaphylactic Reaction, Cardio-respiratory Arrest, Hypotension, Pulmonary Hypertension, Ventricular Fibrillation
on May 07, 2008 Male patient from SPAIN , 76 years of age, was diagnosed with aortic valve replacement, anaesthesia and was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: anaphylactic reaction, cardio-respiratory arrest, hypotension, pulmonary hypertension (What is pulmonary hypertension?), ventricular fibrillation. Aprotinin dosage: . During the same period patient was treated with REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ).

5705952-5 | Bradycardia, Cardiac Disorder, Cardiac Failure Congestive, Disseminated Intravascular Coagulation, Hypotension, Supraventricular Tachycardia, Ventricular Fibrillation
Patient was taking Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac disorder, cardiac failure congestive, disseminated intravascular coagulation, hypotension, supraventricular tachycardia, ventricular fibrillation on Mar 19, 2008 from UNITED STATES Additional patient health information: Male patient , 65 years of age, was diagnosed with aortic aneurysm (What is aortic aneurysm?) and. Aprotinin dosage: As Used: 1 Ml.

5647304-2 | Atrial Thrombosis, Vena Cava Thrombosis, Venous Thrombosis
Adverse event was reported on Feb 11, 2008 by a Male patient taking Aprotinin (View Usage) (Dosage: ) was diagnosed with ventricular assist device insertion, coagulopathy and. Location: UNITED STATES , 59 years of age, Patient had the following side effects: atrial thrombosis, vena cava thrombosis, venous thrombosis. During the same period patient was treated with RFVIIA (RECOMBINANT FACTOR VIIA) (View Rfviia (recombinant Factor Viia) Review and Rfviia (recombinant Factor Viia) Label ), HEPARIN (View Heparin Review and Heparin Label ), PLATELETS (View Platelets Review and Platelets Label ), FRESH FROZEN PLASMA (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), CRYOPRECIPITATED AHF (View Cryoprecipitated Ahf Review and Cryoprecipitated Ahf Label ).

5636230-0 | Coronary Artery Thrombosis, Graft Thrombosis, Hypotension, No Therapeutic Response, Ventricular Hypokinesia
on Feb 20, 2008 Male patient from UNITED STATES , 54 years of age, weighting 152.0 lb, was diagnosed with aortic valve replacement, coronary artery bypass (What is coronary artery bypass?) and was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: coronary artery thrombosis, graft thrombosis, hypotension, no therapeutic response, ventricular hypokinesia. Aprotinin dosage: 50 Ml/hr Iv 20 Miu Iv X 1 Pump Prime 2 Mill.kiu - 200 Ml.

5627646-7 | Anuria, Livedo Reticularis, Skin Discolouration, Thrombocytopenia, Thrombosis, Thrombotic Microangiopathy
on Feb 05, 2008 Male patient from GERMANY , 69 years of age, was diagnosed with haemorrhage, hypocoagulable state and was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, livedo reticularis, skin discolouration, thrombocytopenia, thrombosis, thrombotic microangiopathy. Aprotinin dosage: . During the same period patient was treated with FIBRINOGEN (View Fibrinogen Review and Fibrinogen Label ). Patient was hospitalized.

5583192-0 | Anaphylactoid Reaction
Patient was taking Aprotinin (View Usage). Patient had the following side effects: anaphylactoid reaction on Jan 03, 2008 from UNITED STATES Additional patient health information: Female patient , 61 years of age, . Aprotinin dosage: Test Dose Once Iv. Patient was hospitalized.

5507460-3 | Pulmonary Hypertension, Renal Failure Acute, Thrombotic Thrombocytopenic Purpura
Adverse event was reported on Oct 31, 2007 by a Female patient taking Aprotinin (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, After Aprotinin was administered, patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?), renal failure acute, thrombotic thrombocytopenic purpura.

5507457-3 | Blood Creatine Increased, Blood Creatine Phosphokinase Increased, Renal Failure Acute, Renal Tubular Necrosis
on Oct 31, 2007 Male patient from UNITED STATES , 83 years of age, was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine increased, blood creatine phosphokinase increased, renal failure acute, renal tubular necrosis. Aprotinin dosage: . Patient was hospitalized.

5507456-1 | Lung Disorder, Renal Failure Acute, Respiratory Disorder, Sepsis
on Oct 31, 2007 Male patient from UNITED STATES , 83 years of age, was treated with Aprotinin (View Usage). Patient had the following side effects: lung disorder, renal failure acute, respiratory disorder, sepsis (What is sepsis?). Aprotinin dosage: . Patient was hospitalized.

5507455-X | Cardiac Arrest, Myocardial Infarction, Renal Failure, Shock
Patient was taking Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), myocardial infarction, renal failure, shock on Oct 31, 2007 from UNITED STATES Additional patient health information: Male patient , 79 years of age, . Aprotinin dosage: .

5507454-8 | Blood Creatine Phosphokinase Increased, Hyperglycaemia, Renal Impairment, Shock
Adverse event was reported on Oct 31, 2007 by a Female patient taking Aprotinin (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, hyperglycaemia, renal impairment, shock.

5507452-4 | Blood Creatine Increased, Renal Impairment, Renal Tubular Necrosis, Thrombocytopenia
on Oct 31, 2007 Male patient from UNITED STATES , 72 years of age, was treated with Aprotinin (View Usage). Patient had the following side effects: blood creatine increased, renal impairment, renal tubular necrosis, thrombocytopenia. Aprotinin dosage: . Patient was hospitalized.

5505939-1 | Cardiac Arrest, Myocardial Infarction, Renal Failure, Shock
on Oct 31, 2007 Male patient from UNITED STATES , 79 years of age, was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), myocardial infarction, renal failure, shock. Aprotinin dosage: .

5505938-X | Blood Creatine Phosphokinase Increased, Hyperglycaemia, Renal Impairment, Shock
Patient was taking Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, hyperglycaemia, renal impairment, shock on Oct 31, 2007 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Aprotinin dosage: .

5505937-8 | Pulmonary Hypertension, Renal Failure Acute, Thrombotic Thrombocytopenic Purpura
Adverse event was reported on Oct 31, 2007 by a Female patient taking Aprotinin (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, Patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?), renal failure acute, thrombotic thrombocytopenic purpura.

5473290-4 | Anaphylactic Shock, Bronchospasm, Coagulopathy, Hypotension, Oxygen Saturation Decreased, Peripheral Ischaemia, Pulmonary Oedema, Rash Erythematous, Renal Failure
on Sep 26, 2007 Male patient from CANADA , 54 years of age, was diagnosed with heart transplant (What is heart transplant?) and was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: anaphylactic shock, bronchospasm, coagulopathy, hypotension, oxygen saturation decreased, peripheral ischaemia, pulmonary oedema, rash erythematous, renal failure. Aprotinin dosage: .

5462988-X | Blood Lactic Acid Increased, Coagulopathy, Haemorrhage, Hypotension, Intracardiac Thrombus, Oliguria, Pulmonary Oedema, Ventricular Failure
on Sep 11, 2007 Female patient from UNITED STATES , 78 years of age, was diagnosed with aortic valve replacement, blood product transfusion, platelet transfusion and was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, coagulopathy, haemorrhage, hypotension, intracardiac thrombus, oliguria, pulmonary oedema, ventricular failure. Aprotinin dosage: . During the same period patient was treated with PROTAMINE SULFATE (View Protamine Sulfate Review and Protamine Sulfate Label ), FRESH FROZEN PLASMA (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), PLATELETS (View Platelets Review and Platelets Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TRIAMTERENE (View Triamterene Review and Triamterene Label ).

5441682-5 | Cardiac Arrest, Myocardial Infarction, Renal Failure, Shock
Patient was taking Aprotinin (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), myocardial infarction, renal failure, shock on Aug 22, 2007 from UNITED STATES Additional patient health information: Male patient , 79 years of age, . Aprotinin dosage: .

5441681-3 | Pulmonary Hypertension, Renal Failure Acute, Thrombotic Thrombocytopenic Purpura
Adverse event was reported on Aug 22, 2007 by a Female patient taking Aprotinin (View Usage) (Dosage: ) . Location: UNITED STATES , 51 years of age, After Aprotinin was administered, patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?), renal failure acute, thrombotic thrombocytopenic purpura.

5441680-1 | Lung Disorder, Renal Failure Acute, Respiratory Disorder, Sepsis
on Aug 22, 2007 Male patient from UNITED STATES , 83 years of age, was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder, renal failure acute, respiratory disorder, sepsis (What is sepsis?). Aprotinin dosage: . Patient was hospitalized.

5441679-5 | Blood Creatine Phosphokinase Increased, Hyperglycaemia, Renal Impairment, Shock
on Aug 22, 2007 Female patient from UNITED STATES , 68 years of age, was treated with Aprotinin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, hyperglycaemia, renal impairment, shock. Aprotinin dosage: .

5441678-3 | Blood Creatine Increased, Blood Creatine Phosphokinase Increased, Renal Failure Acute, Renal Tubular Necrosis
Patient was taking Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: blood creatine increased, blood creatine phosphokinase increased, renal failure acute, renal tubular necrosis on Aug 22, 2007 from UNITED STATES Additional patient health information: Male patient , 83 years of age, . Aprotinin dosage: . Patient was hospitalized.

5441675-8 | Blood Creatine Increased, Renal Impairment, Renal Tubular Necrosis, Thrombocytopenia
Adverse event was reported on Aug 22, 2007 by a Male patient taking Aprotinin (View Usage) (Dosage: ) . Location: UNITED STATES , 72 years of age, Patient experienced the following unwanted or unexpected effects: blood creatine increased, renal impairment, renal tubular necrosis, thrombocytopenia. Patient was hospitalized.

5420636-9 | Coronary Artery Thrombosis, Electrocardiogram St Segment Elevation, Myocardial Ischaemia
on Aug 08, 2007 Male patient from AUSTRALIA , 78 years of age, was diagnosed with prophylaxis, sedation, anaesthesia and was treated with Aprotinin (View Usage). Patient had the following side effects: coronary artery thrombosis, electrocardiogram st segment elevation, myocardial ischaemia. Aprotinin dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

5403940-X | Anaphylactic Reaction, Fibrinolysis Abnormal, Hypotension, Tachycardia
on Aug 02, 2007 Male patient from IRELAND , 46 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: anaphylactic reaction, fibrinolysis abnormal, hypotension, tachycardia. Aprotinin dosage: . During the same period patient was treated with OCTAPLAS (Unit Dose: 200 Ml) (View Octaplas Review and Octaplas Label ).

5369998-1 | Intracardiac Thrombus
Patient was taking Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: intracardiac thrombus on Jun 22, 2007 from CANADA Additional patient health information: Female patient , 67 years of age, weighting 116.8 lb, was diagnosed with cardiopulmonary bypass, anaemia, bleeding time prolonged and. Aprotinin dosage: . During the same period patient was treated with PROTAMINE SULFATE (View Protamine Sulfate Review and Protamine Sulfate Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), PLATELETS (View Platelets Review and Platelets Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5331345-9 | Failure To Anastomose, Fungal Sepsis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema, Renal Failure
Adverse event was reported on May 17, 2007 by a Male patient taking Aprotinin (View Usage) (Dosage: ) was diagnosed with lung infection and. Location: GERMANY , 69 years of age, weighting 198.4 lb, Patient had the following side effects: failure to anastomose, fungal sepsis, hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema, renal failure. During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5322457-4 | Fungal Sepsis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema, Renal Failure, Retroperitoneal Haemorrhage
on Mar 22, 2007 Male patient from GERMANY , 69 years of age, weighting 198.4 lb, was diagnosed with lung infection and was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: fungal sepsis, hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema, renal failure, retroperitoneal haemorrhage. Aprotinin dosage: . During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5313917-0 | Fungal Sepsis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema, Renal Failure, Retroperitoneal Haemorrhage
on Mar 22, 2007 Male patient from GERMANY , 69 years of age, weighting 198.4 lb, was diagnosed with lung infection and was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: fungal sepsis, hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema, renal failure, retroperitoneal haemorrhage. Aprotinin dosage: . During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5294682-2 | Renal Failure Acute
Patient was taking Aprotinin (View Usage). Patient had the following side effects: renal failure acute on Apr 09, 2007 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 198.4 lb, . Aprotinin dosage: Test Dose + Bolus.

5291982-7 | Renal Failure Acute
Adverse event was reported on Apr 06, 2007 by a Male patient taking Aprotinin (View Usage) (Dosage: ) was diagnosed with coronary artery bypass (What is coronary artery bypass?) and. Location: UNITED STATES , 78 years of age, After Aprotinin was administered, patient had the following side effects: renal failure acute. Patient was hospitalized.

5266028-7 | Post Procedural Myocardial Infarction, Urine Output Decreased, Vascular Graft Occlusion
on Mar 13, 2007 Female patient from UNITED STATES , 69 years of age, weighting 235.9 lb, was diagnosed with haemorrhage control and was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural myocardial infarction, urine output decreased, vascular graft occlusion. Aprotinin dosage: Iv. Patient was hospitalized.

5263497-3 | Fungal Sepsis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema, Renal Failure, Retroperitoneal Haemorrhage
on Mar 08, 2007 Male patient from GERMANY , 69 years of age, weighting 198.4 lb, was diagnosed with lung infection and was treated with Aprotinin (View Usage). Patient had the following side effects: fungal sepsis, hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema, renal failure, retroperitoneal haemorrhage. Aprotinin dosage: . During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (Total Daily Dose: 400 Mg) (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5217719-5 | Aortic Thrombosis, Intracardiac Thrombus
Patient was taking Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: aortic thrombosis, intracardiac thrombus on Jan 19, 2007 from GERMANY Additional patient health information: Female patient , 75 years of age, was diagnosed with aortic aneurysm (What is aortic aneurysm?) and. Aprotinin dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), PROTAMINE SULFATE (View Protamine Sulfate Review and Protamine Sulfate Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), FRESH FROZEN PLASMA (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), PLATELETS (View Platelets Review and Platelets Label ).

5217717-1 | Graft Thrombosis, Intracardiac Thrombus
Adverse event was reported on Jan 19, 2007 by a Female patient taking Aprotinin (View Usage) (Dosage: ) was diagnosed with aortic aneurysm repair and. Location: GERMANY , 60 years of age, Patient experienced the following unwanted or unexpected effects: graft thrombosis, intracardiac thrombus. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), PROTAMIN SULFATE (View Protamin Sulfate Review and Protamin Sulfate Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), FRESH FROZEN PLASMA (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ), PLATELETS (View Platelets Review and Platelets Label ).

5207051-8 | Fungal Sepsis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema, Renal Failure, Retroperitoneal Haemorrhage
on Jan 09, 2007 Male patient from GERMANY , 69 years of age, weighting 198.4 lb, was diagnosed with lung infection and was treated with Aprotinin (View Usage). Patient had the following side effects: fungal sepsis, hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema, renal failure, retroperitoneal haemorrhage. Aprotinin dosage: . During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (Total Daily Dose: 400 Mg) (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5164340-3 | Aspergillosis, Bronchopulmonary Aspergillosis, Fungal Sepsis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema
on Sep 19, 2006 Male patient from GERMANY , 69 years of age, weighting 198.4 lb, was diagnosed with lung infection and was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: aspergillosis, bronchopulmonary aspergillosis, fungal sepsis, hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema. Aprotinin dosage: . During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (Total Daily Dose: 400 Mg) (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5162473-9 | Leg Amputation, Renal Failure Acute, Thrombosis
Patient was taking Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: leg amputation, renal failure acute, thrombosis on Nov 29, 2006 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 205.0 lb, was diagnosed with coronary artery bypass (What is coronary artery bypass?) and. Aprotinin dosage: . Patient was hospitalized and became disabled.

5157688-X | Aspergillosis, Fungal Sepsis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema, Renal Failure
Adverse event was reported on Sep 19, 2006 by a Male patient taking Aprotinin (View Usage) (Dosage: ) was diagnosed with lung infection and. Location: GERMANY , 69 years of age, weighting 198.4 lb, Patient had the following side effects: aspergillosis, fungal sepsis, hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema, renal failure. During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (Total Daily Dose: 400 Mg) (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5151159-2 | Aspergillosis, Aspiration, Bronchopulmonary Aspergillosis, Colon Cancer, Dialysis, Fungal Sepsis, Gastritis Erosive, Hepatic Failure, Hypotension
on Sep 19, 2006 Male patient from GERMANY , 69 years of age, weighting 198.4 lb, was diagnosed with lung infection and was treated with Aprotinin (View Usage). After Aprotinin was administered, patient had the following side effects: aspergillosis, aspiration, bronchopulmonary aspergillosis, colon cancer, dialysis (What is dialysis?), fungal sepsis, gastritis erosive, hepatic failure, hypotension. Aprotinin dosage: . During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (Total Daily Dose: 400 Mg) (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5143749-8 | Dialysis, Hepatic Failure, Hypotension, Ileus, Large Intestinal Haemorrhage, Neurological Symptom, Pulmonary Oedema, Renal Failure, Retroperitoneal Haemorrhage
on Sep 19, 2006 Male patient from GERMANY , 69 years of age, weighting 198.4 lb, was diagnosed with lung infection and was treated with Aprotinin (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), hepatic failure, hypotension, ileus, large intestinal haemorrhage, neurological symptom, pulmonary oedema, renal failure, retroperitoneal haemorrhage. Aprotinin dosage: . During the same period patient was treated with TAZOBAC (Total Daily Dose: 9 Mg) (View Tazobac Review and Tazobac Label ), CIPROFLOXACIN (Total Daily Dose: 400 Mg) (View Ciprofloxacin Review and Ciprofloxacin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5143103-9 | Anaesthetic Complication, Cardio-respiratory Arrest, Procedural Hypotension
Patient was taking Aprotinin (View Usage). Patient had the following side effects: anaesthetic complication, cardio-respiratory arrest, procedural hypotension on Oct 31, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 203.0 lb, was diagnosed with haemorrhage, prophylaxis, thrombosis and. Aprotinin dosage: 280mg Once Iv. Patient was hospitalized.